中外健康文摘
中外健康文摘
중외건강문적
WORLD HEALTH DIGEST
2014年
11期
12-12,13
,共2页
结肠炎%临床治疗%内服与外用药物
結腸炎%臨床治療%內服與外用藥物
결장염%림상치료%내복여외용약물
colitis%clinical treatment%oral and topical medications
目的:探讨临床治疗结肠炎的方法及效果。方法:选取2011~2013年我院收治的26例结肠炎患者为例,根据随机数字表法原则分组,将其中12例实施常规西药治疗者设为对照组,将14例采取内服与外用药物进行联合救治者设为观察组,评估两组的临床治疗结局,并总结治疗经验。结果:观察组14例患者经治疗后,有显效、有效例数共13例,临床总有效率是92.9%,与对照组的66.7%相对比,差异明显(P<0.05)。治疗期间观察组未见1例出现不适,而对照组有4例(33.3%)发生不良反应,两组比较差异明显(P<0.05)。结论:为结肠炎患者实施内服与外用药物进行联合救治,能够保证临床疗效,并且具有安全、可靠的特点,是今后临床提高溃疡性结肠炎救治水平的关键,建议进一步普及。
目的:探討臨床治療結腸炎的方法及效果。方法:選取2011~2013年我院收治的26例結腸炎患者為例,根據隨機數字錶法原則分組,將其中12例實施常規西藥治療者設為對照組,將14例採取內服與外用藥物進行聯閤救治者設為觀察組,評估兩組的臨床治療結跼,併總結治療經驗。結果:觀察組14例患者經治療後,有顯效、有效例數共13例,臨床總有效率是92.9%,與對照組的66.7%相對比,差異明顯(P<0.05)。治療期間觀察組未見1例齣現不適,而對照組有4例(33.3%)髮生不良反應,兩組比較差異明顯(P<0.05)。結論:為結腸炎患者實施內服與外用藥物進行聯閤救治,能夠保證臨床療效,併且具有安全、可靠的特點,是今後臨床提高潰瘍性結腸炎救治水平的關鍵,建議進一步普及。
목적:탐토림상치료결장염적방법급효과。방법:선취2011~2013년아원수치적26례결장염환자위례,근거수궤수자표법원칙분조,장기중12례실시상규서약치료자설위대조조,장14례채취내복여외용약물진행연합구치자설위관찰조,평고량조적림상치료결국,병총결치료경험。결과:관찰조14례환자경치료후,유현효、유효례수공13례,림상총유효솔시92.9%,여대조조적66.7%상대비,차이명현(P<0.05)。치료기간관찰조미견1례출현불괄,이대조조유4례(33.3%)발생불량반응,량조비교차이명현(P<0.05)。결론:위결장염환자실시내복여외용약물진행연합구치,능구보증림상료효,병차구유안전、가고적특점,시금후림상제고궤양성결장염구치수평적관건,건의진일보보급。
Objective: To investigate the clinical treatment of colitis methods and results. Methods: 2011 ~ 2013 in our hospital 26 cases of colitis patients , for example, the principle of grouping according to the random number table , the implementation of the 12 cases of conventional Western medicine treatment as the control group , the 14 cases of oral and topical drugs taken combined treatment group were set to observe , evaluate clinical outcomes between the two groups , and summarize the treatment experience. Results: The 14 patients after treatment , there is markedly effective cases of 13 cases, the total clinical efficiency is 92.9% and 66.7% in the control group contrast, significant differences (P <0.05). Observed during the treatment group and no one case of discomfort , while the control group, 4 patients ( 33.3% ) adverse reactions , the difference was significant (P <0.05). Conclusion: The implementation of colitis oral treatment with topical joint , to ensure that the clinical efficacy, and have a safe, reliable features, is the key to the future of clinical improve the level of treatment of ulcerative colitis , and recommended further spread.